Working to develop the scientific basis for a permanent regulatory framework for anthroposophic medicinal products in Europe

Evaluation of AM and AMPs as a whole system

Use, safety

 

  1. Jong MC, van Wietmarschen H, Glockmann A, Baars EW, Hamre HJ. Safety of Anthroposophic Medicinal Products: An analysis of adverse drug reactions from German pharmacovigilance databases. Drugs - Real World Outcomes 2021. https://doi.org/10.1007/s40801-021-00262-7
  2. Hamre HJ, Glockmann A, Marti J, Soldner G. Mapping physicians’ experiences with medicinal products from whole medical systems: A descriptive analysis of the Vademecum of Anthroposophic Medicines. Complement Med Res 2020; https://doi.org/10.1159/000507541
  3. Hamre HJ, Glockmann A, Heckenbach K, Matthes H. Use and safety of anthroposophic medicinal products: an analysis of 44,662 patients from the EvaMed Pharmacovigilance Network. Drugs - Real World Outcomes 2017;4(4):199-213. https://doi.org/10.1007/s40801-017-0118-5
  4. Jong MC, Jong MU, Baars EW. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases. Pharmacoepidemiol Drug Saf 2012;21(12):1295-301. https://doi.org/10.1002/pds.3298
  5. Büssing A, Ostermann T, Heusser P, Matthiessen PF. Usage of alternative medical systems, acupuncture, homeopathy and anthroposophic medicine, by older German adults. Zhong Xi Yi Jie He Xue Bao 2011;9(8):847-56. https://doi.org/10.3736/jcim20110806
  6. Hamre HJ, Glockmann A, Fischer M, Riley DS, Baars E, Kiene H. Use and safety of anthroposophic medications for acute respiratory and ear infections: a prospective cohort study. Drug Target Insights 2007;2:209-19. http://www.ncbi.nlm.nih.gov/pubmed/21901075
  7. Hamre HJ, Witt CM, Glockmann A, Tröger W, Willich SN, Kiene H. Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis. Drug Saf 2006;29(12):1173-89. https://doi.org/10.2165/00002018-200629120-00008